Market Closed -
Other stock markets
|
After market 01:29:24 am | |||
41.6 EUR | +4.13% | 42.45 | +2.04% |
25/04 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
18/03 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
Business Summary
Number of employees: 224
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
FYB202
71.5
%
| 3 | 6.1 % | 37 | 71.5 % | +1,350.16% |
FYB201
28.5
%
| 12 | 28.5 % | 15 | 28.5 % | +22.76% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
67.2
%
| 10 | 24.6 % | 52 | 67.2 % | +399.81% |
Germany
32.8
%
| 32 | 75.4 % | 25 | 32.8 % | -20.56% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stefan Glombitza
CEO | Chief Executive Officer | - | 01/16/01 |
Enno Spillner
DFI | Director of Finance/CFO | 55 | 01/23/01 |
Andreas Seidl
CTO | Chief Tech/Sci/R&D Officer | - | 01/22/01 |
Sabrina Müller
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | 53 | 01/22/01 | |
Meike Heger
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Olaf Stiller
FOU | Founder | 47 | 01/07/01 |
Peter Wendeln
BRD | Director/Board Member | 59 | - |
Klaus Röhrig
BRD | Director/Board Member | 47 | 10/20/10 |
Wolfgang Essler
BRD | Director/Board Member | - | 25/23/25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,656,902 | 7,446,341 ( 42.17 %) | 0 | 42.17 % |
Company contact information
Formycon AG
Fraunhoferstraße 15 Martinsried, Planegg
82152, Munich
+49 89 864 667 100
http://formycon.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.24% | 753M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- FYB Stock
- Company Formycon AG